Nxera Pharma
4565.T
$6.87
Share price
9.46%
Change (1 day)
-52.19%
Change (1 year)
Categories
EPS for Nxera Pharma (4565.T)
EPS in 2024 (TTM): -$1.08
According to Nxera Pharma's latest financial reports the company's current EPS (TTM) is -$1.07. In 2023 the company made an earnings per share (EPS) of -$0.83 a decrease over its 2022 EPS that were of $0.04791.
EPS history for Nxera Pharma from 2005 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -$1.08 | 30.61% |
| 2023 | -$0.83 | -1829.25% |
| 2022 | $0.04791 | -67.15% |
| 2021 | $0.15 | -40.17% |
| 2020 | $0.24 | 5.97% |
| 2019 | $0.23 | -124.17% |
| 2018 | -$0.95 | -157.64% |
| 2017 | $1.65 | -691.98% |
| 2016 | -$0.28 | -366.52% |
| 2015 | $0.10 | -74.61% |
| 2014 | $0.41 | 45.12% |
| 2013 | $0.28 | -142.56% |
| 2012 | -$0.67 | 4.42% |
| 2011 | -$0.64 | 18.94% |
| 2010 | -$0.54 | -52.47% |
| 2009 | -$1.13 | -161% |
| 2008 | $1.85 | -205.26% |
| 2007 | -$1.76 | 23.33% |
| 2006 | -$1.43 | 42.13% |
| 2005 | -$1.00 |